FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Researchers Find Alzheimers Potential in Semaglutide

[ Price : $8.95]

Researchers from Case Western Reserve University School of Medicine report that semaglutide may reduce the risk of Alzheimer's dis...

ASHP Sees 277 Active Drug Shortages

[ Price : $8.95]

The American Society of Health-System Pharmacists says there were 277 drug shortages as of September, down from an all-time high o...

Safety Alert on Regener-Eyes Eye Drops

[ Price : $8.95]

An FDA safety alert warns about Regener-Eyes manufactured by Regenerative Processing Plant because the eye drops likely contain am...

Priority Review for Glioma Imaging Agent

[ Price : $8.95]

FDA accepts for priority review a Telix NDA for Pixclara (18F-floretyrosine), a positron emission tomography agent for glioma imag...

Alto Neuro Depression Study Fails

[ Price : $8.95]

Alto Neuroscience says a study of its major depressive disorder investigational drug did not meet its primary endpoint.

Vaccine Panel to Discuss RSV Pediatric Vaccine

[ Price : $8.95]

Federal Register notice: FDA announces a 12/12 Vaccines and Related Biological Products Advisory Committee meeting to discuss cons...

Pinnacle Making Illegal Amniotic Products: FDA

[ Price : $8.95]

FDA warns Phoenix, AZ-based Pinnacle Transplant Technologies that it is illegally manufacturing and marketing amniotic products th...

Add Semaglutide to DDC Lists: Novo Nordisk

[ Price : $8.95]

Novo Nordisk asks FDA to add its semaglutide products to the lists of drugs that should not be compounded.

FDA Approves Expanded Abrysvo Indication

[ Price : $8.95]

FDA approves an expanded indication for Pfizers Abrysvo RSV vaccine to include adults from age 18 and up.

CA Man Pleads Guilty to Selling Unapproved Drugs

[ Price : $8.95]

A California man operating a company called Warrior Labz SARMs pleads guilty to selling unapproved drugs after receiving an FDA Wa...